Table of Contents USA Bioengineered Protein Drugs Market Report 2012-2023 1 Bioengineered Protein Drugs Overview 1.1 Product Overview and Scope of Bioengineered Protein Drugs 1.2 Classification of Bioengineered Protein Drugs by Product Category 1.2.1 USA Bioengineered Protein Drugs Sales (K Units) Comparison by Types (2012-2023) 1.2.2 USA Bioengineered Protein Drugs Sales (K Units) Market Share by Types in 2017 1.2.3 Therapeutic Proteins 1.2.4 Monoclonal Antibodies 1.2.5 Vaccines 1.3 USA Bioengineered Protein Drugs Market by Application/End Users 1.3.1 USA Bioengineered Protein Drugs (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Diabetes and Hormonal Disorders 1.3.3 Genetic and Fertility Disorders 1.3.4 Cancers 1.3.5 Organ Transplants 1.3.6 Others 1.4 USA Bioengineered Protein Drugs Market by Region 1.4.1 USA Bioengineered Protein Drugs Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Northeast Status and Prospect (2012-2023) 1.4.3 Midwest Status and Prospect (2012-2023) 1.4.4 South Status and Prospect (2012-2023) 1.4.5 West Status and Prospect (2012-2023) 1.5 USA Sales and Revenue ofSales and Revenue of Bioengineered Protein Drugs (2012-2023) 1.5.1 USA Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2023) 1.5.2 USA Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Bioengineered Protein Drugs 2.2 Raw Material Analysis of Bioengineered Protein Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Bioengineered Protein Drugs 2.4 Other Costs Analysis of Bioengineered Protein Drugs 2.5 Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs 2.6 Manufacturing Process Analysis of Bioengineered Protein Drugs 2.7 Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2018 2.8 Downstream Buyers 3 USA Bioengineered Protein Drugs Players/Suppliers Profiles and Sales Data 3.1 Abbott Laboratories 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Abbott Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Abbott Laboratories Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.1.5 Abbott Laboratories Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.2 F. Hoffmann-La Roche Ltd 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 F. Hoffmann-La Roche Ltd Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.2.5 F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.3 Amgen, Inc. 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Amgen, Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Amgen, Inc. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.3.5 Amgen, Inc. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.4 Bayer AG 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Bayer AG Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Bayer AG Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.4.5 Bayer AG Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.5 Merck & Co., Inc. 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Merck & Co., Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Merck & Co., Inc. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.5.5 Merck & Co., Inc. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.6 Dr. Reddy's Laboratories Ltd. 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Dr. Reddy's Laboratories Ltd. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.6.5 Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.7 Biocon Ltd. 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Biocon Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Biocon Ltd. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.7.5 Biocon Ltd. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.8 Eli Lilly and Company 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Eli Lilly and Company Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Eli Lilly and Company Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.8.5 Eli Lilly and Company Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.9 Sanofi 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Sanofi Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.9.5 Sanofi Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.10 GlaxoSmithKline plc 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 GlaxoSmithKline plc Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 GlaxoSmithKline plc Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.10.5 GlaxoSmithKline plc Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.11 Johnson & Johnson 3.12 JanssenNovartis AG 3.13 Panacea Biotec 3.14 ProBioGen AG 4 USA Bioengineered Protein Drugs Competition by Players/Manufacturers, Region, Type and Application 4.1 USA Bioengineered Protein Drugs Market Competition by Players/Manufacturers 4.1.1 USA Bioengineered Protein Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 USA Bioengineered Protein Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 USA Bioengineered Protein Drugs Sales and Revenue by Type 4.2.1 USA Bioengineered Protein Drugs Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 USA Bioengineered Protein Drugs Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 USA Bioengineered Protein Drugs Sales and Revenue by Application 4.3.1 USA Bioengineered Protein Drugs Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 USA Bioengineered Protein Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 USA Bioengineered Protein Drugs Sales (K Units) by Application 5 Northeast Bioengineered Protein Drugs (Sales, Revenue and Price) 5.1 Northeast Bioengineered Protein Drugs Sales and Value (2012-2017) 5.1.1 Northeast Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Northeast Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 5.1.3 Northeast Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 5.2 Northeast Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 5.3 Northeast Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 6 Midwest Bioengineered Protein Drugs (Sales, Revenue and Price) 6.1 Midwest Bioengineered Protein Drugs Sales and Value (2012-2017) 6.1.1 Midwest Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 6.1.2 Midwest Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 6.1.3 Midwest Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 6.2 Midwest Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 6.3 Midwest Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 7 South Bioengineered Protein Drugs (Sales, Revenue and Price) 7.1 South Bioengineered Protein Drugs Sales and Value (2012-2017) 7.1.1 South Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 7.1.2 South Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 7.1.3 South Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 7.2 South Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 7.3 South Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 8 West Bioengineered Protein Drugs (Sales, Revenue and Price) 8.1 West Bioengineered Protein Drugs Sales and Value (2012-2017) 8.1.1 West Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) 8.1.2 West Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 8.1.3 West Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) 8.2 West Bioengineered Protein Drugs Sales (K Units) and Market Share by Type 8.3 West Bioengineered Protein Drugs Sales (K Units) and Market Share by Application 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Direct Marketing 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List 12 USA Bioengineered Protein Drugs Market Forecast (2018-2023) 12.1 USA Bioengineered Protein Drugs Sales (K Units), Revenue and Price Forecast (2018-2023) 12.1.1 USA Bioengineered Protein Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) 12.1.2 USA Bioengineered Protein Drugs Revenue and Growth Rate Forecast (2018-2023) 12.1.3 USA Bioengineered Protein Drugs Price and Trend Forecast (2018-2023) 12.2 USA Bioengineered Protein Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.1 USA Bioengineered Protein Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 12.2.2 USA Bioengineered Protein Drugs Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.3 Northeast Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.4 Midwest Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.5 Midwest Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.6 West Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.3 USA Bioengineered Protein Drugs Sales, Revenue and Price Forecast by Type (2018-2023) 12.3.1 USA Bioengineered Protein Drugs Sales Forecast by Type (2018-2023) 12.3.2 USA Bioengineered Protein Drugs Revenue Forecast by Type (2018-2023) 12.3.3 USA Bioengineered Protein Drugs Price Forecast by Type (2018-2023) 12.4 USA Bioengineered Protein Drugs Sales Forecast by Application (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer

List of Tables and Figures Figure USA Market Size (Million USD) Comparison 2012-2023 Table USA Market Bioengineered Protein Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table USA Bioengineered Protein Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table USA Bioengineered Protein Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of Bioengineered Protein Drugs Table USA Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure USA Bioengineered Protein Drugs Sales (K Units) Market Share by Types in 2017 Figure Therapeutic Proteins Picture Figure Monoclonal Antibodies Picture Figure Vaccines Picture Table USA Bioengineered Protein Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure USA Sales Market Share of Bioengineered Protein Drugs by Applications in 2017 Figure Diabetes and Hormonal Disorders Examples Figure Genetic and Fertility Disorders Examples Figure Cancers Examples Table USA Market Bioengineered Protein Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure Northeast Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Midwest Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure South Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure West Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure USA Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2023) Figure USA Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Bioengineered Protein Drugs Table Industry News List of Bioengineered Protein Drugs Figure Industry Chain Structure of Bioengineered Protein Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs in 2017 Figure Manufacturing Process Analysis of Bioengineered Protein Drugs Table Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2017 Table Major Buyers of Bioengineered Protein Drugs Table Abbott Laboratories Basic Information List Table Abbott Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Abbott Laboratories Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Abbott Laboratories Bioengineered Protein Drugs Sales USA Market Share (%) (2012-2017) Figure Abbott Laboratories Bioengineered Protein Drugs Revenue USA Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Abbott Laboratories Bioengineered Protein Drugs Volume in and Its Application Share Table Abbott Laboratories Bioengineered Protein Drugs Volume in and Its Application Share Table Abbott Laboratories Bioengineered Protein Drugs Volume in and Its Application Share Table F. Hoffmann-La Roche Ltd Basic Information List Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales USA Market Share (%) (2012-2017) Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Revenue USA Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in and Its Application Share Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in and Its Application Share Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in and Its Application Share Table Amgen, Inc. Basic Information List Table Amgen, Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Amgen, Inc. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Amgen, Inc. Bioengineered Protein Drugs Sales USA Market Share (%) (2012-2017) Figure Amgen, Inc. Bioengineered Protein Drugs Revenue USA Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Amgen, Inc. Bioengineered Protein Drugs Volume in and Its Application Share Table Amgen, Inc. Bioengineered Protein Drugs Volume in and Its Application Share Table Amgen, Inc. Bioengineered Protein Drugs Volume in and Its Application Share Table Bayer AG Basic Information List Table Bayer AG Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Bayer AG Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Bayer AG Bioengineered Protein Drugs Sales USA Market Share (%) (2012-2017) Figure Bayer AG Bioengineered Protein Drugs Revenue USA Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Bayer AG Bioengineered Protein Drugs Volume in and Its Application Share Table Bayer AG Bioengineered Protein Drugs Volume in and Its Application Share Table Bayer AG Bioengineered Protein Drugs Volume in and Its Application Share Table Merck & Co., Inc. Basic Information List Table Merck & Co., Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Merck & Co., Inc. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Merck & Co., Inc. Bioengineered Protein Drugs Sales USA Market Share (%) (2012-2017) Figure Merck & Co., Inc. Bioengineered Protein Drugs Revenue USA Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Merck & Co., Inc. Bioengineered Protein Drugs Volume in and Its Application Share Table Merck & Co., Inc. Bioengineered Protein Drugs Volume in and Its Application Share Table Merck & Co., Inc. Bioengineered Protein Drugs Volume in and Its Application Share Table Dr. Reddy's Laboratories Ltd. Basic Information List Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales USA Market Share (%) (2012-2017) Figure Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Revenue USA Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in and Its Application Share Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in and Its Application Share Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in and Its Application Share Table Biocon Ltd. Basic Information List Table Biocon Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Biocon Ltd. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Biocon Ltd. Bioengineered Protein Drugs Sales USA Market Share (%) (2012-2017) Figure Biocon Ltd. Bioengineered Protein Drugs Revenue USA Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Biocon Ltd. Bioengineered Protein Drugs Volume in and Its Application Share Table Biocon Ltd. Bioengineered Protein Drugs Volume in and Its Application Share Table Biocon Ltd. Bioengineered Protein Drugs Volume in and Its Application Share Table Eli Lilly and Company Basic Information List Table Eli Lilly and Company Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Eli Lilly and Company Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Eli Lilly and Company Bioengineered Protein Drugs Sales USA Market Share (%) (2012-2017) Figure Eli Lilly and Company Bioengineered Protein Drugs Revenue USA Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Eli Lilly and Company Bioengineered Protein Drugs Volume in and Its Application Share Table Eli Lilly and Company Bioengineered Protein Drugs Volume in and Its Application Share Table Eli Lilly and Company Bioengineered Protein Drugs Volume in and Its Application Share Table Sanofi Basic Information List Table Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Sanofi Bioengineered Protein Drugs Sales USA Market Share (%) (2012-2017) Figure Sanofi Bioengineered Protein Drugs Revenue USA Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sanofi Bioengineered Protein Drugs Volume in and Its Application Share Table Sanofi Bioengineered Protein Drugs Volume in and Its Application Share Table Sanofi Bioengineered Protein Drugs Volume in and Its Application Share Table Company GlaxoSmithKline plc Basic Information List Table Company GlaxoSmithKline plc Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company GlaxoSmithKline plc Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Company GlaxoSmithKline plc Bioengineered Protein Drugs Sales USA Market Share (%) (2012-2017) Figure Company GlaxoSmithKline plc Bioengineered Protein Drugs Revenue USA Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company GlaxoSmithKline plc Bioengineered Protein Drugs Volume in and Its Application Share Table Company GlaxoSmithKline plc Bioengineered Protein Drugs Volume in and Its Application Share Table Company GlaxoSmithKline plc Bioengineered Protein Drugs Volume in and Its Application Share Table USA Bioengineered Protein Drugs Sales (K Units) by Players/Manufacturers (2012-2017) Table USA Bioengineered Protein Drugs Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 USA Bioengineered Protein Drugs Sales Market Share (%) by Players/Manufacturers Figure 2017 USA Bioengineered Protein Drugs Sales Share by Players/Manufacturers Table USA Bioengineered Protein Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017) Table USA Bioengineered Protein Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 USA Bioengineered Protein Drugs Revenue Market Share (%) Players Figure 2017 USA Bioengineered Protein Drugs Revenue Market Share (%) Players Table USA Bioengineered Protein Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) Table USA Bioengineered Protein Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of Bioengineered Protein Drugs by Type (2012-2017) Figure USA Bioengineered Protein Drugs Sales Growth Rate (%) by Type (2012-2017) Table USA Bioengineered Protein Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017) Table USA Bioengineered Protein Drugs Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Bioengineered Protein Drugs by Type (2012-2017) Figure USA Bioengineered Protein Drugs Revenue Growth Rate by Type (2012-2017) Table USA Bioengineered Protein Drugs Sales (K Units) and Market Share by Regions (2012-2017) Table USA Bioengineered Protein Drugs Sales Share by Regions (2012-2017) Figure Sales Market Share of Bioengineered Protein Drugs by Regions (2012-2017) Figure USA Bioengineered Protein Drugs Sales Market Share by Regions in 2017 Table USA Bioengineered Protein Drugs Revenue (Million USD) and Market Share by Regions (2012-2017) Table USA Bioengineered Protein Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Bioengineered Protein Drugs by Regions (2012-2017) Figure USA Bioengineered Protein Drugs Revenue Market Share by Regions in 2017 Table USA Bioengineered Protein Drugs Sales (K Units) and Market Share by Application (2012-2017) Table USA Bioengineered Protein Drugs Sales Share (%) by Application (2012-2017) Figure USA Bioengineered Protein Drugs Sales Market Share by Application (2012-2017) Figure USA Bioengineered Protein Drugs Sales Market Share by Application (2012-2017) Figure Northeast Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure Northeast Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northeast Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Northeast Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Northeast Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Northeast Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table Northeast Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table Northeast Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Northeast Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure Midwest Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Midwest Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Midwest Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Midwest Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Midwest Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Midwest Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table Midwest Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table Midwest Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Midwest Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure South Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure South Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table South Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table South Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure South Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table South Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table South Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure South Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Figure West Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure West Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure West Bioengineered Protein Drugs Sales Price (USD/Unit) Trend (2012-2017) Table West Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table West Bioengineered Protein Drugs Sales (K Units) Market Share by Type (2012-2017) Figure West Bioengineered Protein Drugs Sales (K Units) Market Share by Type in 2017 Table West Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table West Bioengineered Protein Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure West Bioengineered Protein Drugs Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure USA Bioengineered Protein Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure USA Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure USA Bioengineered Protein Drugs Price and Trend Forecast (2018-2023) Table USA Bioengineered Protein Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure USA Bioengineered Protein Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure USA Bioengineered Protein Drugs Sales (K Units) Market Share Forecast by Regions in 2023 Table USA Bioengineered Protein Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure USA Bioengineered Protein Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure USA Bioengineered Protein Drugs Revenue Market Share Forecast by Regions in 2023 Figure Northeast Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northeast Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure South Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure West Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure West Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table USA Bioengineered Protein Drugs Sales (K Units) Forecast by Type (2018-2023) Figure USA Bioengineered Protein Drugs Sales Market Share Forecast by Type (2018-2023) Table USA Bioengineered Protein Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure USA Bioengineered Protein Drugs Revenue Market Share Forecast by Type (2018-2023) Table USA Bioengineered Protein Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table USA Bioengineered Protein Drugs Sales (K Units) Forecast by Application (2018-2023) Figure USA Bioengineered Protein Drugs Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Abbott Laboratories F. Hoffmann-La Roche Ltd Amgen, Inc. Bayer AG Merck & Co., Inc. Dr. Reddy's Laboratories Ltd. Biocon Ltd. Eli Lilly and Company Sanofi GlaxoSmithKline plc Johnson & Johnson JanssenNovartis AG Panacea Biotec ProBioGen AG